6550 北極星藥業-KY歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q1 | -473.30% | -8146.51% | -8003.90% | -8008.67% |
| 2024Q4 | -93.37% | -2339.21% | -2350.92% | -2358.33% |
| 2024Q3 | -309.71% | -6689.77% | -6695.83% | -6688.60% |
| 2024Q2 | -11.32% | -1789.98% | -1742.34% | -1752.89% |
| 2024Q1 | -20.13% | -1735.18% | -1450.65% | -1450.41% |
| 2023Q4 | -70.36% | -12197.39% | -11082.18% | -11237.72% |
| 2023Q3 | 12.87% | -60571.66% | -53489.23% | -53607.92% |
| 2023Q2 | 14.92% | -25419.11% | -20464.92% | -20618.31% |
| 2023Q1 | 23.68% | -228802.63% | -177275.00% | -180226.97% |
| 2022Q4 | 24.67% | -35470.22% | -30785.00% | -31381.63% |
| 2022Q3 | 25.21% | -86024.07% | -87724.64% | -87724.64% |
| 2022Q2 | 25.96% | -15726.02% | -16568.78% | -16568.78% |
| 2022Q1 | 18.84% | -7435.66% | -7718.46% | -7719.78% |
| 2021Q4 | 16.01% | -4857.83% | -5110.66% | -5120.38% |
| 2021Q2 | 11.87% | -4874.49% | -4724.61% | -4725.21% |
| 2020Q4 | 25.83% | -3505.11% | -3490.79% | -3490.79% |